Insulin Independence in Newly Diagnosed Type 1 Diabetes Patient following Fenofibrate Treatment

Figure 1

Fenofibrate treatment eliminates the demand for insulin therapy in a newly diagnosed type 1 diabetes patient. A 19-year-old girl diagnosed with type 1 diabetes began taking fenofibrate 160 mg/day seven days after diagnosis. Two units of insulin were taken at day 133 as a precaution when the patient was admitted to a hospital in Sri Lanka with a high fever during her vacation. Data are missing from day 349 to 375 because the patient’s computer was stolen. A few other days are missing data. The patient did not take insulin in this period. Graph shows her random mean blood glucose values and insulin intake.